Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03018119 · ClinicalTrials.gov registry record · NA
Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
A NA study of Postpartum Hemorrhage and Pregnancy Hemorrhage, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT03018119 is a NA study of Postpartum Hemorrhage and Pregnancy Hemorrhage that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 38 participants, below the 201-participant average among 11 other Postpartum Hemorrhage trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03018119, a NA study of Postpartum Hemorrhage and Pregnancy Hemorrhage, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The National Partnership for Maternal Safety (NPMS) developed an obstetric hemorrhage consensus bundle to provide every United States birthing facility consistent, validated practice guidelines. To facilitate implementation of each element of this bundle at the participants large tertiary center, the investigators utilized the Delphi method to identify deficiencies, perceived barriers to implementation, and multidisciplinary consensus on changes with high feasibility and impact on patient care.
Conditions Studied
Interventions
- OTHER Survey
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03018119
The ClinicalTrials.gov registry entry for NCT03018119 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 201-participant average among 11 other Postpartum Hemorrhage trials with a reported enrollment target (81% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Postpartum Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.
NCT03018119 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03018119 about?
NCT03018119 is a clinical study titled "Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method". The National Partnership for Maternal Safety (NPMS) developed an obstetric hemorrhage consensus bundle to provide every United States birthing facility consistent, validated practice guidelines. To facilitate implementation of each element of this bundle at the participants large tertiary center, th...
What is the current status of trial NCT03018119?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2015-11. Estimated completion is 2016-04.
What conditions does trial NCT03018119 study?
This clinical trial studies the following conditions: Postpartum Hemorrhage, Pregnancy Hemorrhage.
What interventions are being tested in trial NCT03018119?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT03018119?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03018119 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
RECRUITING · NA
-
Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping
COMPLETED · NA
-
Active Versus Expectant Management of the Third Stage of Labor
COMPLETED · NA
-
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
COMPLETED · NA
-
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
RECRUITING · Phase 3
-
Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.